glp 1 suicidal thoughts Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study FDA asks for removal of

Anti-obesity effects of -amylase inhibitor enriched-extract from white common beans (Phaseolus vulgaris L.) associated with the modulation of gut microbiota composition in high-fat diet-induced obese rats

A mitochondria-targeted covalent organic framework (COF) prodrug that is selectively activated by high intramitochondrial GSH levels was shown to trigger catalase collapse within the organelle, thereby amplifying local chemodynamic therapy (CDT) through enhanced ROS accumulation and mitochondrial dysfunction

ja.ma/4t1tZrJ This case report describes 2 patients with lichen sclerosus whose symptoms improved with glucagon-like peptide-1 receptor (#GLP-1) agonists

GLP-1 receptor agonists represent a major advancement in weight management, with delivery methods ranging from weekly injections to daily oral tablets